값20202021202220232024TTM판매비·일반관리비——————연구개발——————영업 이익——————비영업 수익, 합계——————이자비용(자본화한 이자 차감 후)——————이자비용을 제외한 비영업 수익——————비정상 수입/지출——————세전소득——————지분법 손익——————세금——————비지배 지분——————세후 기타 수익/비용——————중단된 사업 부문 제외 순이익——————중단된 사업——————순이익——————희석보정——————우선배당——————보통주주에게 귀속되는 희석 순이익——————주당 순이익(기본 EPS)——————희석 주당 순이익 (희석 EPS)——————평균 발행주식수——————희석주식수——————EBITDA——————EBIT——————매출원가——————기타 매출원가——————감가상각 및 무형자산 상각 (현금흐름)——————
Aurora Cannabis Inc. - Common Shares
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. The company began trading on the NYSE on October 23, 2018, using the ticker ACB.
After significant expansion in 2018, the company reduced expenses in the second half of 2019 when the Canadian recreational cannabis market had low sales due to excessive inventory and uncompetitive pricing with the black market. In February 2020, cofounder and chief executive, Terry Booth, resigned, being replaced by Executive Chairman Michael Singer as interim CEO.